SupplementDrug
Bifidobacterium breve clinical trials
- studies test it
- 20
- open now
- 5
- in phase 3
- 1
- first study started
- 2006
Keep track of what changes. Save the bifidobacterium breve studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
19 studies that test it; most in 2019 (4); 1 more planned to start later
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 4 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 5
- Phase 3
- 1
- Phase 4
- 1
- No phase
- 13
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 20
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (2) · Charite University, Berlin, Germany (1) · Aga Khan University (1) · Centre Hospitalier Universitaire de Nice (1) · University College, London (1) · Psychiatric Hospital of the University of Basel (1) · Seattle Children's Hospital (1) · Hvidovre University Hospital (1)
Often tested with
Tested in the same studies.
Streptococcus thermophilus (16) · Bifidobacterium animalis subsp. lactis (16) · Lacteol (16) · Lactobacillus plantarum (16) · Lacticaseibacillus paracasei (16) · Lactobacillus helveticus (16) · Linoleic Acids, Conjugated (1)
Studies
Open first, then newest update. How each study uses bifidobacterium breve is read from its arms, and is right about nine times in ten.
Testing it · 20
- Effect of Bifidobacterium Breve Supplementation on the Onset and Progression of Idiopathic ScoliosisNot yet recruitingNot applicableSecond Affiliated Hospital of Wenzhou Medical UniversityNCT07466511Written as Bifidobacterium breve
- Effects of GLP-1 Formula on GLP-1 and Glucose RegulationRecruitingNot applicableShih Chien HuangNCT07082062Written as GLP-1 formula Group
- Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal JaundiceRecruitingPhase 2Chinese University of Hong KongNCT06087874Written as Vivomixx®
- Effects of a Combined Supplementation of Conjugated Linoleic Acid (CLA) and Probiotics (Vivomixx®) as add-on to a First-line Immunotherapy in Relapsing-remitting Multiple SclerosisRecruitingNot applicableUniversität MünsterNCT05920018Written as Vivomixx®
- Maternal Probiotic Intervention to Improve Gut HealthRecruitingPhase 2International Centre for Diarrhoeal Disease Research, BangladeshNCT06196450Written as Vivomixx
- Maternal Probiotic Intervention to Improve Gut HealthCompletedPhase 2Aga Khan UniversityNCT05922683Written as Vivomixx
- Effects of a Probiotic in HypertensionActive, not recruitingNot applicableCharite University, Berlin, GermanyNCT03906578Written as Vivomixx®
- Impact of Probiotics in HIV-positive Patients With Neurocognitive DisordersCompletedNot applicableCentre Hospitalier Universitaire de NiceNCT04175223Written as Vivomixx
- Efficacy of Vivomixx on Behaviour and Gut Function in Autism Spectrum DisorderCompletedNot applicableUniversity College, LondonNCT03369431Written as Vivomixx
- Probiotic Supplementation in Severe DepressionCompletedNot applicablePsychiatric Hospital of the University of BaselNCT02957591Written as Vivomixx®
- Pilot Study of Probiotics in Pre-diabetic AdolescentsCompletedNot applicableSeattle Children's HospitalNCT03109587Written as Vivomixx
- Effect of Probiotics (Vivomixx®) on Weight, Microbiota and Glucose Tolerance in Obese Pregnant Women and Their NewbornCompletedPhase 4Hvidovre University HospitalNCT02508844Written as Vivomixx®
- Application of Oral Bacteriotherapy to Promote Anal HPV Clearance in HIV Positive IndividualsStatus unknownNot applicableUniversity of Roma La SapienzaNCT04099433Written as Vivomixx
- Can Probiotic Vivomixx Eradicate Colonization With ESBL?CompletedNot applicableLund UniversityNCT03860415Written as Vivomixx
- Gut to Brain Interaction in Autism. Role of Probiotics on Clinical, Biochemical and Neurophysiological ParametersCompletedNot applicableIRCCS Fondazione Stella MarisNCT02708901Written as Vivomixx®
- Vivomixx for Prevention of Bone Loss in Women With Breast Cancer Treated With an Aromatase InhibitorStatus unknownPhase 1/2Tel-Aviv Sourasky Medical CenterNCT03518268Written as Vivomixx
- Effect of Vivomixx® on Neuroinflammation in Patients Withs CirrhosisWithdrawnNot applicableFundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauNCT03236090Written as Vivomixx
- Study of the Effect of Adjunctive Vivomixx® in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis (SBP)WithdrawnPhase 3Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauNCT02552862Written as Vivomixx®
- Cytokine Profile in Children With Celiac DiseaseCompletedPhase 1/2University Medical Centre MariborNCT02244047Written as Bifidobacterium breve
- Effect of Bifidobacterium on Irritable Bowel SyndromeStatus unknownNot applicableTohoku UniversityNCT00737841Written as Bifidobacterium breve
Given in every arm · 1 — bifidobacterium breve is usual care beside what is tested
Codes
What other systems call bifidobacterium breve · ClinicalTrials.gg INT017117
- RxNorm 2110011One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| RxNorm | 2110011 | — | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.